(Date:5/9/2008)...re-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYNO ), ...ray of,light-based aesthetic treatment systems, to... from the Korea Food & Drug Administration (KFDA),...removal of pigmented,lesions., Introduced in the ...ynosure flagship product approved for marketing in...
(Date:5/9/2008)...wire-USNewswire/ -- International,Rescue Committee...d four,additional teams are on standby for deploym...le outbreak of water-borne diseases in cyclone-rav...d in the villages I assessed today and,the survivo...r," says the,IRC,s emergency coordinator, Gordon B...
(Date:5/9/2008)...e-USNewswire/ -- Metaverse developer,Simuality LLC...able human,suffering in Myanmar in the wake of Cyc...eloped and are being placed in high-traffic locati...dination being arranged via the,Simuality welcome ...ondlife/Simuality/106/83/41 )., In addition, link...
(Date:5/9/2008)...ne wards off fusarium wilt on leaves , ,...ed approach to helping tomatoes fight a fungus tha...sts. , In agriculture, there,s an ongoing battl...lve along with their host plant,s immune system, a...ne way to increase protection is through disease r...
Breaking Medicine News(10 mins):Health News:Cynosure's Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval 2Health News:Cynosure's Accolade(TM) Workstation for Pigmented Lesions Receives Korean Regulatory Approval 3Health News:International Rescue Committee Mobilizes More Emergency Teams for Myanmar; Warns of Massive Health Disaster Unless Aid Reaches Cyclone Survivors Fast 2...t was found that transferring growth factor genes ...ance.// In angina, the blood supply to the heart i...the body tries to compensate by growing new blood ...some unknown reason, this process, known as angiog...
...85, is a leading developer of an oxygen-carrying b...y blood substitute undergoing clinical trials that...sidered a substitute for acute blood loss in traum...ss used to manufacture the blood substitute, essen...
...eating in certain susceptible individuals. Researc... at the factors that make some people// susceptibl...nificant symptom. In a new study, they find that t...h lack of sunshine encouraging more eating. This ...
...ersity at Buffalo School of Dental Medicine ,they ...ray// may serve as an accurate early-warning syste...e study was ushered in a population with a high in...study move us closer to the use of panoramic denta...
Other Medicine News:(Date:5/8/2008)... BOSTON, May 8 /- The Cancer Res... the nation,s top cancer centers, is asking,303 mi...r by donating $1 to,cancer research efforts this M...dubbed the "Infinite Power of One(TM)" has two key...atters into their own hands by,joining together to...
(Date:5/8/2008)... TAMPA, Fla., May 8 /-...harmaceutical company, today announced results fro...(morphine sulfate,extended-release with sequestere...clinically relevant features addressing abuse liab...ofile. The Phase I and II,studies, presented at th...
(Date:5/8/2008)... NEW HAVEN, Conn., May 8 /PRNewswire-FirstCal...today announced the start of an investigator-spons...cer agent Cloretazine(R),(VNP40101M) in combinatio...sly untreated acute myelogenous leukemia (AML) and...ial is being conducted under the,direction of Elle...
(Date:5/8/2008)... - Memorial Sloan-Kettering Cancer Center Inves...CA-Negative Ovarian Cancer Patients -, BRISBANE, ... today,announced the expansion of Phase 2 clinical...ovarian cancer. This is the third major clinical t...t 6 months, expanding on,on-going trials in breast...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Novel Cooling Therapy May Have Aided Injured Football Player 1209 1Novel Cooling Therapy May Have Aided Injured Football Player 1209 2Novel Cooling Therapy May Have Aided Injured Football Player 1209 3Novel Cooling Therapy May Have Aided Injured Football Player 1209 4Leaderless movement proves illusive 380 1Leaderless movement proves illusive 380 2Joint Juice Launches New Ready to Drink Glucosamine 26 Vitamin Enhanced Dietary Supplement Water Nationwide 1207 1Joint Juice Launches New Ready to Drink Glucosamine 26 Vitamin Enhanced Dietary Supplement Water Nationwide 1207 2Frances Decker Named Mid Atlantic Region Sales Executive for AllOne Health Management Solutions 1205 1Frances Decker Named Mid Atlantic Region Sales Executive for AllOne Health Management Solutions 1205 2... significant additional protection against,infecti...cervical,cancer candidate vaccine, PHILADELPHIA, J...m an interim analysis of a Phase III study show th...r candidate vaccine,provides up to 100 percent pr...sed by the most common types of human papillomavir...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5...CHEM EZ is a small bench top chemistry analyzer th...erformed on reagent strips with results available ...sts per hour. The instrument accepts whole blood s...ipe of a magnetic card. At the conclusion of testi...
Veriteq's Refrigerator and Freezer Monitoring System is a data logger monitoring system for refrigerators and freezers that is easy to install. Using a building's existing ethernet network, Veriteq's
The ThermaViewer is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store
This requiring no water for use, it provides convenient, long-lasting hand hygiene to physically clean hands when routine hand washing is either not an option or is not convenient. Hibistat allows yo
Medicine Products: